Sponsor

Alaunos Therapeutics

Clinical research sponsor

Published trials8

Recruiting shown0

Roles1

SourceClinicalTrials.gov

Clinical trials

8 shown

Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRsNCT05292859 · lead sponsor · 2023-03-01

COMPLETED

Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid TumorsNCT05194735 · lead sponsor · 2022-04-04

TERMINATED

HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid TumorsNCT05124743 · lead sponsor · 2021-09-24

TERMINATED

A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Breast CancerNCT02423902 · lead sponsor · 2015-07-18

TERMINATED

Adenoviral Vector Monotherapy or Combination With Chemotherapy in Subjects With Recurrent/Metastatic Breast Cancer.NCT01703754 · lead sponsor · 2013-04-04

TERMINATED

Study of Palifosfamide-tris in Combination With Carboplatin and Etoposide in Chemotherapy Naïve Patients With Extensive-Stage Small Cell Lung Cancer (The MATISSE Study)NCT01555710 · lead sponsor · 2012-06-08

TERMINATED

Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With MalignanciesNCT01242072 · lead sponsor · 2010-12-01

COMPLETED

Study of a Novel Indibulin Dosing Schedule for the Treatment of Metastatic Breast CancerNCT01113970 · lead sponsor · 2010-04-06

TERMINATED

Sponsor roles

lead sponsor8

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.